Zum Inhalt springen
Sponsorship
Die MVF-Knowledge-HubsFrisch aus der Forschung. Täglich aktualisiert!

Suchen Sie in Hunderten nationaler und internationaler Datenbanken nach dem neuesten Studienwissen der angegebenen Themengebiete und/oder lassen Sie sich werktäglich per Newsletter informieren. Die Newsfeeds werden auf deutsch übersetzt and nach Übertragbarkeit auf das deutsche Gesundheits-/Versorgungssystem ausgewählt:

Zu den Knowledge-Hubs

Archive:

What is important in the treatment of type 2 diabetes?

Health preference research plays a crucial role in supporting patients and physicians in shared decision-making. Such studies reveal what is important to patients in their treatment, thereby enabling recommendations that better meet their needs – improving individualized care, promoting treatment adherence, and potentially reducing complications (Cramer 2004). The presented study investigated the value of treatments by assessing patient preferences. The aim was to gain scientifically sound insights into the preferences of people with type 2 diabetes. In particular, the study examined which aspects are important to patients when choosing medications for combination therapy.

05.10.2025
Molecular testing in cholangiocarcinoma diagnostics

Findings from a systematic survey of outpatient reimbursement structures and a hospital survey

05.10.2025
Evaluation of digital health solutions from the perspective of healthcare practice

NADI (Value and Acceptance of Digital Health) is a research project funded by the Innovation Fund of the Federal Joint Committee (G-BA) and conducted by a consortium of Hannover Medical School, the Technical University of Berlin, and Neubrandenburg University of Applied Sciences. The project aims to systematically analyze the opportunities and challenges of digital health solutions and to develop an evaluation framework tailored to healthcare practice. As part of the project, Neubrandenburg University of Applied Sciences is conducting a large-scale preference survey among healthcare professionals.

05.10.2025
The procedure for data collection during use for early benefit assessment

A critical review six years after the GSAV

14.08.2025
Evidential (care) concepts for psychosomatic illnesses

Series (Part 48): Psychosomatic Health Services Research, Department of General Internal Medicine and Psychosomatics, Heidelberg University Hospital

04.08.2025
§ 25b SGB V: more than a bridging technology

8th Online Conference "Vaccination Status 2025 – Section 25b SGB V: Opportunities, Obstacles, Solutions"

04.08.2025
Medical innovation meets investment backlog

White Paper “Radioligand Therapy in Germany”

04.08.2025
No additional benefit for formal reasons

Details on the benefit assessment of Balversa (erdafitinib)

04.08.2025
Central Data Protection Supervision for Health Data

BDI publication “Data protection hurdles in the industrial healthcare sector”

04.08.2025
Brinkmeier: “A sign of hope”

Launch of the project “Berlin Patient Guides for Integrated Stroke Aftercare”

04.08.2025

Do you want to leave us already?

Subscribe to our newsletter quickly. Then you can be sure that you won't miss anything.